Cipla Ltd
NSE:CIPLA

Watchlist Manager
Cipla Ltd Logo
Cipla Ltd
NSE:CIPLA
Watchlist
Price: 1 508 INR -0.62% Market Closed
Market Cap: 1.2T INR

Relative Value

The Relative Value of one CIPLA stock under the Base Case scenario is hidden INR. Compared to the current market price of 1 508 INR, Cipla Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CIPLA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
26
vs Industry
27
Median 3Y
4.3
Median 5Y
4
Industry
2.6
Forward
4.1
vs History
92
vs Industry
19
Median 3Y
27.7
Median 5Y
28.8
Industry
21.6
Forward
24.5
vs History
23
vs Industry
15
Median 3Y
27.5
Median 5Y
25
Industry
16.5
vs History
61
vs Industry
11
Median 3Y
49.5
Median 5Y
49.6
Industry
22.5
vs History
79
vs Industry
17
Median 3Y
4
Median 5Y
3.9
Industry
2.3
vs History
31
vs Industry
29
Median 3Y
4
Median 5Y
3.7
Industry
2.9
Forward
3.7
vs History
52
vs Industry
33
Median 3Y
5.9
Median 5Y
5.9
Industry
5.5
vs History
61
vs Industry
22
Median 3Y
15.8
Median 5Y
16.1
Industry
13
Forward
15.8
vs History
79
vs Industry
22
Median 3Y
19.3
Median 5Y
20.5
Industry
16.6
Forward
18.9
vs History
25
vs Industry
17
Median 3Y
25.6
Median 5Y
23.3
Industry
15.8
vs History
15
vs Industry
13
Median 3Y
38.8
Median 5Y
34
Industry
19.1
vs History
41
vs Industry
16
Median 3Y
4.5
Median 5Y
4.2
Industry
1.9

Multiples Across Competitors

CIPLA Competitors Multiples
Cipla Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Cipla Ltd
NSE:CIPLA
1.2T INR 4.3 22.4 15.5 18.4
US
Eli Lilly and Co
NYSE:LLY
999.3B USD 16.8 54.3 36.4 39
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
515.7B USD 5.6 20.5 16.8 21.7
CH
Roche Holding AG
SIX:ROG
256.3B CHF 4.2 27.2 11.6 13.6
UK
AstraZeneca PLC
LSE:AZN
211.1B GBP 4.9 30.1 108.4 158.6
CH
Novartis AG
SIX:NOVN
205.8B CHF 4.6 18 11.4 14.7
US
Merck & Co Inc
NYSE:MRK
247.7B USD 3.9 13 9.3 11
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.5 9.5 11
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
150.6B USD 2.4 15.3 7.7 10.6
P/E Multiple
Earnings Growth PEG
IN
Cipla Ltd
NSE:CIPLA
Average P/E: 23.8
22.4
4%
5.6
US
Eli Lilly and Co
NYSE:LLY
54.3
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.5
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.2
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.1
38%
0.8
CH
Novartis AG
SIX:NOVN
18
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.5
4%
3.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
15.3
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Cipla Ltd
NSE:CIPLA
Average EV/EBITDA: 400.4
15.5
5%
3.1
US
Eli Lilly and Co
NYSE:LLY
36.4
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.8
9%
1.9
CH
Roche Holding AG
SIX:ROG
11.6
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
11.4
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.3
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.5
2%
4.7
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.7
1%
7.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Cipla Ltd
NSE:CIPLA
Average EV/EBIT: 1 711.9
18.4
4%
4.6
US
Eli Lilly and Co
NYSE:LLY
39
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.7
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.6
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
CH
Novartis AG
SIX:NOVN
14.7
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.6
8%
1.3